For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Alliance Pharmaceutical Corp.

Calculating rank

USPTO Granted Patents = 92

% Expired Patents = 1.1

EPO Patents = 2

Trademarks = 10

Forward Citations = 4,218

Loading Chart...

Loading Chart...

69 inventors (with patents filed for the assignee):

Ernest George Schutt (23 out of 67 patents)

Jean G Riess (21 out of 31 patents)

Jeffry G Weers (20 out of 60 patents)

4. Nicholas Simon Faithfull (12 out of 13 patents)

5. David M Long, Jr (11 out of 19 patents)

6. Leila Zarif (11 out of 11 patents)

7. David P Evitts (9 out of 13 patents)

8. Charles David Anderson (9 out of 13 patents)

9. David H Klein (8 out of 9 patents)

10. Bernard Pucci (7 out of 11 patents)

11. Mark A Walters (7 out of 7 patents)

12. Andre A Pavia (7 out of 7 patents)

13. W Dean Kirkland (7 out of 7 patents)

14. Marie-Pierre Krafft (7 out of 8 patents)

15. Peter E Keipert (6 out of 6 patents)

Core Competencies:

Fluorocarbon Emulsions

Oxygen Carriers

Ultrasound Imaging

Microbubbles

Contrast Media

Therapeutic Agents

Blood Substitutes

Ischemic Damage

Biomedical Applications

Liquid Ventilation

Gas Emulsions

Pharmaceutical Delivery

92 patents: Sort by Forward Citations

1. 8748497 - Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses (2014-06-10),

2. 6679859 - Amelioration of ischemic damage using synthetic oxygen carriers (2004-01-20),

3. 6420436 - Imaging contrast media and methods of use (2002-07-16),

4. 6390977 - System and methods for measuring oxygenation parameters (2002-05-21),

5. 6372195 - Mixed gas microbubble compositions (2002-04-16),

6. 6368613 - Use of fluorocarbons for diagnosis and treatment of articular disorders (2002-04-09),

7. 6361792 - Lipid dispersions and methods of use (2002-03-26),

8. 6359006 - Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications (2002-03-19),

9. 6289892 - Partial liquid breathing of fluorocarbons (2001-09-18),

10. 6287539 - Methods of imaging using osmotically stabilized microbubble preparations (2001-09-11),

11. 6280745 - Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions (2001-08-28),

12. 6280705 - Kits & systems for ultrasonic imaging (2001-08-28),

13. 6280704 - Ultrasonic imaging system utilizing a long-persistence contrast agent (2001-08-28),

14. 6258339 - Osmotically stabilized microbubble preparations (2001-07-10),

15. 6242472 - Methods for the pulmonary delivery of biological agents (2001-06-05),

Company Overview

Alliance Pharmaceutical Corp., based in San Diego, CA, specializes in the development of innovative fluorocarbon emulsions. The company focuses on creating advanced oxygen carriers and therapeutic agents, particularly for applications in ultrasound imaging and contrast media. Their research encompasses microbubbles and blood substitutes, aiming to address ischemic damage and enhance medical imaging techniques. Alliance Pharmaceutical is dedicated to pioneering solutions that improve patient outcomes in critical care and diagnostic settings.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

92 Patents

#68 in San Diego, CA

#956 in California

#4,086 in US

#8,390 in the World

San Diego, CA, United States of America

Alliance Pharmaceutical Corp.

Forward Citations = 4,218

69 inventors:

Ernest George Schutt (23 out of 67 patents)

Jean G Riess (21 out of 31 patents)

Jeffry G Weers (20 out of 60 patents)

4. Nicholas Simon Faithfull (12 out of 13 patents)

5. David M Long, Jr (11 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alliance Pharmaceutical Corp.. Retrieved from https://idiyas.com/company/alliance-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…